UniSuper Management’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
– Sell
-800
Closed -$147K – 999
2024
Q1
$147K Buy
800
+400
+100% +$76.2K ﹤0.01% 957
2023
Q4
$71.9K Hold
400
– – ﹤0.01% 689
2023
Q3
$63.6K Hold
400
– – ﹤0.01% 672
2023
Q2
$56.6K Buy
+400
New +$64.1K ﹤0.01% 692

Other funds holding RGEN

UniSuper Management's RGEN Position: Q2 2024 in Review

UniSuper Management sold out of Repligen (RGEN) in Q2 2024, closing a stake of 800 shares — an estimated $147K sold.

UniSuper Management first reported a position in RGEN in Q2 2023 and held it in 4 quarters. The position peaked at $147K in Q1 2024. 455 funds tracked by Wall St. Rank hold RGEN as of Q2 2024.

  • UniSuper Management reported no remaining Repligen position as of Q2 2024 after selling out during the quarter.
  • UniSuper Management sold 800 Repligen shares in Q2 2024, an estimated $147K.
  • UniSuper Management first reported a position in Repligen in Q2 2023 and held it in 4 quarters.
  • UniSuper Management's Repligen position peaked at $147K in Q1 2024.
  • 455 funds tracked by Wall St. Rank held Repligen as of Q2 2024.

Based on UniSuper Management's 13F filing for Q2 2024, filed 5 Aug 2024.